A pilot study of vitamin E versus vitamin E and pioglitazone for the treatment of nonalcoholic steatohepatitis (Q44907394)

7 December 2017

A pilot study of vitamin E versus vitamin E and pioglitazone for the treatment of nonalcoholic steatohepatitis (English)

1 reference

7 December 2017

0 references

0 references

Arun J Sanyal

1

1 reference

7 December 2017

Pouneh S Mofrad

2

1 reference

7 December 2017

Melissa J Contos

3

1 reference

7 December 2017

Carol Sargeant

4

1 reference

7 December 2017

Velimir A Luketic

5

1 reference

7 December 2017

Richard K Sterling

6

1 reference

7 December 2017

R Todd Stravitz

7

1 reference

7 December 2017

Mitchell L Shiffman

8

1 reference

7 December 2017

John Clore

9

1 reference

7 December 2017

Alan S Mills

10

1 reference

7 December 2017

language of work or name

English

0 references

publication date

1 December 2004

1 reference

Clinical Gastroenterology and Hepatology

7 December 2017

1 reference

7 December 2017

2

1 reference

7 December 2017

1107-1115

1 reference

7 December 2017

12

1 reference

AGA technical review on nonalcoholic fatty liver disease

7 December 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900457-4

7 January 2021

Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900457-4

7 January 2021

Association of nonalcoholic fatty liver disease with insulin resistance.

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900457-4

7 January 2021

Nonalcoholic steatohepatitis: association of insulin resistance and mitochondrial abnormalities

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900457-4

7 January 2021

Obesity, insulin resistance, and cardiovascular disease

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900457-4

7 January 2021

Use of Metabolic Markers To Identify Overweight Individuals Who Are Insulin Resistant

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900457-4

7 January 2021

The insulin resistance syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900457-4

7 January 2021

Contribution of hepatic de novo lipogenesis and reesterification of plasma non esterified fatty acids to plasma triglyceride synthesis during non-alcoholic fatty liver disease

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900457-4

7 January 2021

Increased fatty acid uptake and altered fatty acid metabolism in insulin-resistant muscle of obese Zucker rats

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900457-4

7 January 2021

Serum thioredoxin levels as a predictor of steatohepatitis in patients with nonalcoholic fatty liver disease

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900457-4

7 January 2021

Oxidative stress in the pathogenesis of nonalcoholic fatty liver disease, in rats fed with a choline-deficient diet.

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900457-4

7 January 2021

Executive summary of the clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900457-4

7 January 2021

Vitamin E treatment of nonalcoholic steatohepatitis in children: a pilot study

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900457-4

7 January 2021

Troglitazone, a new antidiabetic agent possessing radical scavenging ability, improved decreased skin blood flow in diabetic rats

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900457-4

7 January 2021

Effects of insulin on peripheral and splanchnic glucose metabolism in noninsulin-dependent (type II) diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900457-4

7 January 2021

Calculation of substrate oxidation rates in vivo from gaseous exchange.

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900457-4

7 January 2021

Obesity and reproductive disorders in women

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900457-4

7 January 2021

A pilot study of pioglitazone treatment for nonalcoholic steatohepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900457-4

7 January 2021

Pioglitazone, a peroxisome proliferator-activated receptor-gamma agonist, attenuates myocardial ischemia/reperfusion injury in a rat model

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900457-4

7 January 2021

ACRP30/adiponectin: an adipokine regulating glucose and lipid metabolism

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900457-4

7 January 2021

The mechanisms by which both heterozygous peroxisome proliferator-activated receptor gamma (PPARgamma) deficiency and PPARgamma agonist improve insulin resistance

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900457-4

7 January 2021

Clinical and histologic spectrum of nonalcoholic fatty liver disease associated with normal ALT values

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900457-4

7 January 2021

In vivo effects of hyperinsulinemia on lipogenic enzymes and glucose transporter expression in rat liver and adipose tissues

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900457-4

7 January 2021

Pathophysiology and pathogenesis of visceral fat obesity

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900457-4

7 January 2021

Insulin signaling: mechanisms altered in insulin resistance

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900457-4

7 January 2021

Characterizing the effects of saturated fatty acids on insulin signaling and ceramide and diacylglycerol accumulation in 3T3-L1 adipocytes and C2C12 myotubes

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900457-4

7 January 2021

Nonalcoholic fatty liver disease: a feature of the metabolic syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900457-4

7 January 2021

Mitochondria in steatohepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900457-4

7 January 2021

Antioxidant vitamins and risk of cardiovascular disease. Review of large-scale randomised trials

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2804%2900457-4

7 January 2021

10.1016/S1542-3565(04)00457-4

Identifiers

DOI

1 reference

7 December 2017

1 reference